Skip to main content
Secondary Menu
AHA Member Center
About
Press Center
AHA Help Center
Search
Advocacy
Quick Links
Action Center
We Care, We Vote
Advocacy Agenda
Advocacy Issues
Action Alerts
Special Bulletins
Advisories
Letters
Testimony
Press Releases
Topics
Access & Health Coverage
Affordability
Behavioral Health
Compliance
Current & Emerging Payment Models
Reducing Health Outcome Disparities
Technology and Cybersecurity
Quality and Patient Safety
Regulatory Relief
Workforce
Issues for You
The Value of Health Systems
The 340B Drug Pricing Program
Rural Health and Critical Access Hospitals
Hospitals Against Violence | #HAVhope
Post-acute Care
Maternal and Child Health
Commercial Health Plan Accountability
Cybersecurity & Risk Advisory
Physician Leaders
Nurse Leadership
Trustees
Health Systems
Providers with Health Plans
Teaching Hospitals
Surprise Billing
Career Resources
Current AHA Openings
Certification Center
American Organization for Nursing Leadership
Professional Membership Groups
AHA Trustee Services
Data & Insights
Fast Facts on U.S. Hospitals
AHA Health Care Workforce Scan
Market Scan
AHA Center for Health Innovation
AHA Data Products
AHA Coding Clinic
National Uniform Billing Committee (NUBC)
Hospitals and Systems
Community Health Data
AHA Funded Partnerships
Sustainability Roadmap
Resource Center
AHA Online Store
Education & Events
Events & Webinars Calendar
AHA Leadership Summit
AHA Rural Health Care Leadership Conference
AHA Annual Membership Meeting
Webinar Recordings
AHA Team Training
Individual Membership Organization Events
AHA Knowledge Exchange
Innovation Resources
Sponsorship Information
News
News Articles
Advancing Health Podcast
My AHA Connect app
AHA Stat Blog
AHA News RSS Feed
Subscribe to AHA Today
Perspective
Chair File
Leadership Dialogue
Individuals & Communities
Telling the Hospital Story
Promoting Healthy Communities
AHA Community Health Improvement
AHA Statement to the House E&C Health Subcommittee Re: "Examining the 340B Drug Pricing Program"
Breadcrumb
Home
Advocacy
Testimony
Comments of the American Hospital Association on the value the 340B program provides to patients and communities.
Key Resources
aha-statement-to-the-house-ec-health-subcommittee-re-examining-the-340b-drug-pricing-program
Related Resources
Advancing Health Podcast
How Legal Advocacy Is Shaping the Future of Health Care
Public
Guides/Reports
More Drug Company Oversight Needed to Maintain Compliance with 340B Program Rules
Public
Issue Landing Page
The 340B Drug Pricing Program
Public
Letter/Comment
AHA Senate Letter Supporting Improving Seniors’ Timely Access to Care Act
Public
Letter/Comment
AHA House Letter Supporting Improving Seniors’ Timely Access to Care Act
Public
Advisory
AHA Summary of House Energy and Commerce Legislative Language
Member
Medicare
340B Drug Pricing Program
